全文获取类型
收费全文 | 4900篇 |
免费 | 323篇 |
国内免费 | 294篇 |
出版年
2024年 | 8篇 |
2023年 | 60篇 |
2022年 | 143篇 |
2021年 | 274篇 |
2020年 | 193篇 |
2019年 | 208篇 |
2018年 | 164篇 |
2017年 | 138篇 |
2016年 | 221篇 |
2015年 | 318篇 |
2014年 | 339篇 |
2013年 | 362篇 |
2012年 | 498篇 |
2011年 | 404篇 |
2010年 | 240篇 |
2009年 | 234篇 |
2008年 | 242篇 |
2007年 | 195篇 |
2006年 | 177篇 |
2005年 | 138篇 |
2004年 | 112篇 |
2003年 | 102篇 |
2002年 | 104篇 |
2001年 | 89篇 |
2000年 | 76篇 |
1999年 | 70篇 |
1998年 | 52篇 |
1997年 | 46篇 |
1996年 | 39篇 |
1995年 | 43篇 |
1994年 | 41篇 |
1993年 | 30篇 |
1992年 | 30篇 |
1991年 | 33篇 |
1990年 | 18篇 |
1989年 | 16篇 |
1988年 | 12篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 10篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1981年 | 4篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1975年 | 2篇 |
1965年 | 1篇 |
排序方式: 共有5517条查询结果,搜索用时 15 毫秒
181.
Luo Shengxue Zhang Panli Zou Peng Wang Cong Liu Bochao Wu Cuiling Li Tingting Zhang Ling Zhang Yuming Li Chengyao 《中国病毒学》2021,36(5):1113-1123
Virologica Sinica - SARS-CoV-2 has caused more than 3.8 million deaths worldwide, and several types of COVID-19 vaccines are urgently approved for use, including adenovirus vectored vaccines.... 相似文献
182.
Xiangqin He Yanyan Yang Qi Wang Jueru Wang Shifang Li Chunrong Li Tingyu Zong Xiaolu Li Ying Zhang Yulin Zou Tao Yu 《Journal of cellular and molecular medicine》2021,25(14):7052-7065
Knowledge regarding the relationship between the molecular mechanisms underlying atherosclerosis (AS) and transfer RNA-derived small RNAs (tsRNAs) is limited. This study illustrated the expression profile of tsRNAs, thus exploring its roles in AS pathogenesis. Small RNA sequencing was performed with four atherosclerotic arterial and four healthy subject samples. Using bioinformatics, the protein-protein interaction network and cellular experiments were constructed to predict the enriched signalling pathways and regulatory roles of tsRNAs in AS. Of the total 315 tsRNAs identified to be dysregulated in the AS group, 131 and 184 were up-regulated and down-regulated, respectively. Interestingly, the pathway of the differentiated expression of tsRNAs in cell adhesion molecules (CAMs) was implicated to be closely associated with AS. Particularly, tRF-Gly-GCC might participate in AS pathogenesis via regulating cell adhesion, proliferation, migration and phenotypic transformation in HUVECs and VSMCs. In conclusion, tsRNAs might help understand the molecular mechanisms of AS better. tRF-Gly-GCC may be a promising target for suppressing abnormal vessels functions, suggesting a novel strategy for preventing the progression of atherosclerosis. 相似文献
183.
184.
Zhou Yuanhao Ye Xiaolin Wang Baikui Ying Jiafu Zeng Zihan Tang Li Wang Qi Zou Peng Zhan Xiaoli Fu Luoqin 《International journal of peptide research and therapeutics》2021,27(3):1605-1613
International Journal of Peptide Research and Therapeutics - Pidotimod has been shown to exhibit immunomodulatory activities and exert protective effects against bacterial infections. This study... 相似文献
185.
Xi Liu Feng Jiang Zhilinag Wang Lang Tang Bin Zou Pengfei Xu Tenghua Yu 《Journal of cellular and molecular medicine》2021,25(1):96-109
Lung cancer is the most aggressive tumour afflicting patients on a global scale. Extracellular vesicle (EV)-delivered microRNAs (miRs) have been reported to play critical roles in cancer development. The current study aimed to investigate the role of hypoxic bone marrow mesenchymal cell (BMSC)-derived EVs containing miR-328-3p in lung cancer. miR-328-3p expression was determined in a set of lung cancer tissues by RT-qPCR. BMSCs were infected with lentivirus-mediated miR-328-3p knock-down and then cultured in normoxic or hypoxic conditions, followed by isolation of EVs. Following ectopic expression and depletion experiments in lung cancer cells, the biological functions of miR-328-3p were analysed using CCK-8 assay, flow cytometry and Transwell assay. Xenograft in nude mice was performed to test the in vivo effects of miR-328-3p delivered by hypoxic BMSC-derived EVs on tumour growth of lung cancer. Finally, the expression of circulating miR-328-3p was detected in the serum of lung cancer patients. miR-328-3p was highly expressed in EVs derived from hypoxic BMSCs. miR-328-3p was delivered to lung cancer cells by hypoxic BMSC-derived EVs, thereby promoting lung cancer cell proliferation, invasion, migration and epithelial-mesenchymal transition. miR-328-3p targeted NF2 to inactivate the Hippo pathway. Moreover, EV-delivered miR-328-3p increased tumour growth in vivo. Additionally, circulating miR-328-3p was bioactive in the serum of lung cancer patients. Taken together, our results demonstrated that hypoxic BMSC-derived EVs could deliver miR-328-3p to lung cancer cells and that miR-328-3p targets the NF2 gene, thereby inhibiting the Hippo pathway to ultimately promote the occurrence and progression of lung cancer. 相似文献
186.
Yu-Shui Ma Ting-Miao Wu Bin Qian Yu-Shan Liu Hua Ding Ming-Ming Fan Ji-Bin Liu Fei Yu Hui-Min Wang Yi Shi Li-Peng Gu Liu Li Lin-Lin Tian Pei-Yao Wang Gao-Ren Wang Zhi-Jun Wu Qi-Fei Zou Chang-Chun Ling Da Fu 《Journal of cellular and molecular medicine》2021,25(8):4040-4052
Hepatocellular cancer (HCC) has been reported to belong to one of the highly vascularized solid tumours accompanied with angiogenesis of human umbilical vein endothelial cells (HUVECs). KDM5A, an attractive drug target, plays a critical role in diverse physiological processes. Thus, this study aims to investigate its role in angiogenesis and underlying mechanisms in HCC. ChIP-qPCR was utilized to validate enrichment of H3K4me3 and KDM5A on the promotor region of miR-433, while dual luciferase assay was carried out to confirm the targeting relationship between miR-433 and FXYD3. Scratch assay, transwell assay, Edu assay, pseudo-tube formation assay and mice with xenografted tumours were conducted to investigate the physiological function of KDM5A-miR-433-FXYD3-PI3K-AKT axis in the progression of HCC after loss- and gain-function assays. KDM5A p-p85 and p-AKT were highly expressed but miR-433 was down-regulated in HCC tissues and cell lines. Depletion of KDM5A led to reduced migrative, invasive and proliferative capacities in HCC cells, including growth and a lowered HUVEC angiogenic capacity in vitro. Furthermore, KDM5A suppressed the expression of miR-433 by demethylating H3K4me3 on its promoterregion. miR-433 negatively targeted FXYD3. Depleting miR-433 or re-expressing FXYD3 restores the reduced migrative, invasive and proliferative capacities, and lowers the HUVEC angiogenic capacity caused by silencing KDM5A. Therefore, KDM5A silencing significantly suppresses HCC tumorigenesis in vivo, accompanied with down-regulated miR-433 and up-regulated FXYD3-PI3K-AKT axis in tumour tissues. Lastly, KDM5A activates the FXYD3-PI3K-AKT axis to enhance angiogenesis in HCC by suppressing miR-433. 相似文献
187.
Li-Li Zou Jian-Rui Li Hu Li Jia-Li Tan Mei-Xi Wang Nan-Nan Liu Rong-Mei Gao Hai-Yan Yan Xue-Kai Wang Biao Dong Yu-Huan Li Zong-Gen Peng 《Journal of cellular and molecular medicine》2021,25(7):3498-3510
Transforming growth factor beta (TGF-β) plays an important role in the viral liver disease progression via controlling viral propagation and mediating inflammation-associated responses. However, the antiviral activities and mechanisms of TGF-β isoforms, including TGF-β1, TGF-β2 and TGF-β3, remain unclear. Here, we demonstrated that all of the three TGF-β isoforms were increased in Huh7.5 cells infected by hepatitis C virus (HCV), but in turn, the elevated TGF-β isoforms could inhibit HCV propagation with different potency in infectious HCV cell culture system. TGF-β isoforms suppressed HCV propagation through interrupting several different stages in the whole HCV life cycle, including virus entry and intracellular replication, in TGF-β/SMAD signalling pathway–dependent and TGF-β/SMAD signalling pathway–independent manners. TGF-β isoforms showed additional anti-HCV activities when combined with each other. However, the elevated TGF-β1 and TGF-β2, not TGF-β3, could also induce liver fibrosis with a high expression of type I collagen alpha-1 and α-smooth muscle actin in LX-2 cells. Our results showed a new insight into TGF-β isoforms in the HCV-related liver disease progression. 相似文献
188.
Wang Xin Dong Chunxiao Zhou Qingjun Duan Haoyun Zou Dulei Gong Yajie Ma Bochao Li Zongyi Shi Weiyun 《Apoptosis : an international journal on programmed cell death》2021,26(11-12):600-611
Apoptosis - Fuchs endothelial corneal dystrophy (FECD) is one of the main causes for corneal endothelial blindness, which is characterized by the progressive decline of corneal endothelial cells.... 相似文献
189.
Wei Liu Chunyu Wang Shengli Wang Kai Zeng Shan Wei Ning Sun Ge Sun Manlin Wang Renlong Zou Wensu Liu Lin Lin Huijuan Song Zining Jin Yue Zhao 《International journal of biological sciences》2021,17(1):188
Androgen receptor (AR) and its variants play vital roles in development and progression of prostate cancer. To clarify the mechanisms involved in the enhancement of their actions would be crucial for understanding the process in prostate cancer and castration-resistant prostate cancer transformation. Here, we provided the evidence to show that pre-mRNA processing factor 6 (PRPF6) acts as a key regulator for action of both AR full length (AR-FL) and AR variant 7 (AR-V7), thereby participating in the enhancement of AR-FL and AR-V7-induced transactivation in prostate cancer. In addition, PRPF6 is recruited to cis-regulatory elements in AR target genes and associates with JMJD1A to enhance AR-induced transactivation. PRPF6 also promotes expression of AR-FL and AR-V7. Moreover, PRPF6 depletion reduces tumor growth in prostate cancer-derived cell lines and results in significant suppression of xenograft tumors even under castration condition in mouse model. Furthermore, PRPF6 is obviously highly expressed in human prostate cancer samples. Collectively, our results suggest PRPF6 is involved in enhancement of oncogenic AR signaling, which support a previously unknown role of PRPF6 during progression of prostate cancer and castration-resistant prostate cancers. 相似文献
190.
Yuexian Li Cheng Sun Yonggang Tan Heying Zhang Yuchao Li Huawei Zou 《International journal of biological sciences》2021,17(2):635
Objectives: Radiotherapy has played a limited role in the treatment of non-small cell lung cancer (NSCLC) due to the risk of tumour radioresistance. We previously established the radioresistant non-small cell lung cancer (NSCLC) cell line H460R. In this study, we identified differentially expressed genes between these radioresistant H460R cells and their radiosensitive parent line. We further evaluated the role of a differentially expressed gene, ITGB1, in NSCLC cell radioresistance and as a potential target for improving radiosensitivity.Materials and Methods: The radiosensitivity of NSCLC cells was evaluated by flow cytometry, colony formation assays, immunofluorescence, and Western blotting. Bioinformatics assay was used to identify the effect of ITGB1 and YAP1 expression in NSCLC tissues.Results: ITGB1 mRNA and protein expression levels were higher in H460R than in the parental H460 cells. We observed lower clonogenic survival and cell viability and a higher rate of apoptosis of ITGB1-knockdown A549 and H460R cells than of wild type cells post-irradiation. Transfection with an ITGB1 short hairpin (sh) RNA enhanced radiation-induced DNA damage and G2/M phase arrest. Moreover, ITGB1 induced epithelial-mesenchymal transition (EMT) of NSCLC cells. Silencing ITGB1 suppressed the expression and intracellular translocation of Yes-associated protein 1 (YAP1), a downstream effector of ITGB1.Conclusions: ITGB1 may induce radioresistance via affecting DNA repair and YAP1-induced EMT. Taken together, our data suggest that ITGB1 is an attractive therapeutic target to overcome NSCLC cell radioresistance. 相似文献